Pharmaceutical News

RSS

HIF-2 inhibitors could be promising target to combat kidney cancer

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

6 Sep 2016

Early life use of antibiotics linked to higher risk of developing allergies later in life

Research presented today (6 September, 2016) at this year's European Respiratory Society International Congress in London, UK shows that exposure to antibiotics early in life is related to increased risk of developing allergies later in life.

6 Sep 2016

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union and, though to a smaller degree, in Japan by 2020, according to new research published in the leading cancer journal Annals of Oncology today (Tuesday).

5 Sep 2016

New discovery offers way to develop vaccine against highly infectious bacteria

Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria--responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."

5 Sep 2016

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors.

5 Sep 2016

Study examines effectiveness of spiritual meditation plus medication intervention for migraines

"Effect of Different Meditation Types on Migraine Headache Medication Use," an article recently published in Behavioral Medicine, examines whether or not, and to what extent, a combination of spiritual meditation and migraine medication affects analgesic medication usage.

2 Sep 2016

McMaster researchers develop better way to deliver medicine to surface of the eye

It's a problem as old and as aggravating as eye drops themselves: as soon as the medicine goes in, almost all of it washes right back out again.

2 Sep 2016

NanoTemper Technologies employs game-changing solutions for faster drug development

Following a successful inaugural meeting in 2014, the 2nd Drug Discovery Forum (DDF) took place on May 8–11, 2016 at the Westin Grand Hotel in Munich.

From NanoTemper Technologies 2 Sep 2016

NanoTemper Technologies to highlight applications of MST, nanoDSF in drug discovery at Biopharma Workshop 2016

NanoTemper Technologies offers MicroScale Thermophoresis (MST) and nanoDSF technology to analyze these parameters in an easy and precise way. To meet the increasing demand for high-throughput applications and unattended operation, NanoTemper Technologies provides fully automated MST and nanoDSF platforms — and combinations of both.

From NanoTemper Technologies 2 Sep 2016

New study provides insights into how regulators support accelerated access to new therapies

It can be challenging for regulators to keep up with advances related to medical drugs and devices. A new analysis and editorial published in the British Journal of Clinical Pharmacology provide insights on how officials are working to support accelerated access to new therapies while also ensuring their safety.

2 Sep 2016

BetterYou’s oral vitamin D sprays win gold and bronze at Best Baby and Toddler Gear Awards by Mummii

An innovative way of boosting the vitamin D levels of expectant mums and infants has been honoured by one of the parenting industries most prestigious award schemes.

From BetterYou Ltd 2 Sep 2016

Study reveals increasing prevalence of marijuana use among US adults

An increasing number of US adults are using marijuana, as fewer people perceive the drug as harmful, according to a survey of over 500000 US adults conducted between 2002 and 2014 published in The Lancet Psychiatry.

2 Sep 2016

New collaborative initiative to develop novel ways of screening drugs for bipolar disorder, schizophrenia

The Johns Hopkins University School of Medicine and the Salk Institute for Biological Studies will co-lead a $15.4 million effort to develop new systems for quickly screening libraries of drugs for potential effectiveness against schizophrenia and bipolar disorder, the National Institute of Mental Health (NIMH) has announced.

2 Sep 2016

Chemists find efficient way to convert organic molecules into new medicines

Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.

2 Sep 2016

RIT professor receives federal award for research to help combat threat of antibiotic-resistant bacteria

A Rochester Institute of Technology professor has received a federal award for research that could help in the critical battle to develop new drugs to combat the drastic rise in the number of antibiotic-resistant bacteria.

2 Sep 2016

Approved dengue vaccine may increase infection in certain settings, research suggests

The only approved vaccine for dengue may actually increase the incidence of dengue infections requiring hospitalization rather than preventing the disease if health officials aren't careful about where they vaccinate, new public health research published Sept. 2 in Science suggests.

1 Sep 2016

Pharmaceutical News

HIF-2 inhibitors could be promising target to combat kidney cancer

Early life use of antibiotics linked to higher risk of developing allergies later in life

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

New discovery offers way to develop vaccine against highly infectious bacteria

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

Study examines effectiveness of spiritual meditation plus medication intervention for migraines

McMaster researchers develop better way to deliver medicine to surface of the eye

NanoTemper Technologies employs game-changing solutions for faster drug development

NanoTemper Technologies to highlight applications of MST, nanoDSF in drug discovery at Biopharma Workshop 2016

New study provides insights into how regulators support accelerated access to new therapies

BetterYou’s oral vitamin D sprays win gold and bronze at Best Baby and Toddler Gear Awards by Mummii

Study reveals increasing prevalence of marijuana use among US adults

New collaborative initiative to develop novel ways of screening drugs for bipolar disorder, schizophrenia

Chemists find efficient way to convert organic molecules into new medicines

RIT professor receives federal award for research to help combat threat of antibiotic-resistant bacteria

Approved dengue vaccine may increase infection in certain settings, research suggests

Exposure to antibiotics in early life linked to increased food allergy risk

Research findings of protein may form foundation for new approach to antibiotics

Added benefit not proven for new combination therapy in multiple myeloma

Scientists combine immunotherapy with chemotherapy to eliminate cancer recurrence

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News